ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1925

Characterizing Phenotypic Changes by SARS-CoV-2 Variant in Multisystem Inflammatory Syndrome in Children (MIS-C): A Single Institution Case Series

Sandy D. Hong1 and Emma Leisinger2, 1University of Iowa Stead Family Children's Hospital, Iowa City, IA, 2University of Iowa, Iowa City, IA

Meeting: ACR Convergence 2022

Keywords: Miscellaneous Rheumatic and Inflammatory Diseases, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Pediatric Rheumatology – Clinical Poster III: Other

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Multisystem inflammatory syndrome in children (MIS-C) is a severe hyper-inflammatory condition associated with a recent SARS-CoV-2 infection. Case reports began in April of 2020 from Italy and the United Kingdom documenting cases of children with shock-like illness and features of Kawasaki Disease (KD). Epidemiologic data demonstrates a latent rise and peak of MIS-C cases approximately 2-4 weeks after peak population infection. This study evaluated the phenotypic presentations of children diagnosed with MIS-C compared with the dominant SARS-CoV-2 variant type in the population throughout the course of the pandemic.

Methods: A retrospective chart reviews was performed on patients treated for MIS-C at the University of Iowa Stead Family Children’s Hospital (UISFCH) from April 2020 to April 2022. Phenotyping was based on main clinical features at presentation. All patients met CDC guidelines for MIS-C. Variant category was determined by State of Iowa Department of Public Health data outlining the dominant variant by in state testing. The original strain indicates the time for which variant testing was not available at the state level. (See figure 1) Patient classification based on presenting features fell within 5 phenotypes; those with gastrointestinal involvement either fit criteria for mixed-abdominal or shock phenotypes, and those with dermatological features were characterized as KD-like or mixed-rash phenotypes. Patients with respiratory features were categorized as respiratory phenotype. (See Figure 2)

Results: Seventy children with median age of 8 (interquartile range (IQR) 0.58-19) years met the criteria for MIS-C. 28 patients (40%) were characterized as shock phenotype, 20 patients (29%) KD-like, 15 patients (21%) mixed abdominal, 6 patients (9%) mixed rash, and 1 patient (1%) respiratory. The phenotypic breakdown per SARS-CoV-2 variant showed that during the delta variant patients with gastrointestinal involvement with and without shock were the dominant phenotype at 70% (17/22) with 75% (13/17) of those being patients having shock. A Fisher’s Exact Test comparing the gastrointestinal versus dermatologic phenotypes by variant yielded a p-value of 0.229.

Conclusion: Patients diagnosed with MIS-C during the time frame of the original, and alpha strain presented with similar amounts of gastrointestinal and dermatologic features, but as new variants emerged, it was evident that the phenotype proportions shifted. During the delta strain the majority of patients presented with gastrointestinal involvement and shock. We demonstrate the rise of MIS-C after population peaks in the original and delta strain, and a distinctive lack of cases following the surge of the omicron strain. The lack of a peak may be due to omicron causing less immune activation, previous infection in our pediatric population, and the effect of vaccination.

Supporting image 1

Figure 1: MIS-C case count per month was compared with positive tests (in thousands) over the course of the pandemic. Background coloring indicates the dominant SARS-CoV_2 variant in the state of Iowa. Original variant (grey) outlines the time in which state testing for variant type was not readily available.

Supporting image 2

Figure 2: Flow diagram outlining classification of phenotype based on presenting organ system involvement. All patients met MIS-C criteria. Gastrointestinal involvement included abdominal pain, nausea, vomiting, and diarrhea. Dermatologic involvement included conjunctivitis muco-cutaneous changes, periorbital edema, erythema of hands and feet and morbilliform rashes. KD criteria was based on the AHA KD 2017 Guidelines.

Supporting image 3

Figure 3: Cases of MIS-C admitted at UISFCH over the course of the pandemic displayed in admissions per month. Patients were categorically colored based on phenotype. Purple coloring indicates gastrointestinal involvement; patients with shock in dark purple and mixed-abdominal (no shock) in light purple. Green coloring indicated dermatologic features with those meeting criteria for KD or incomplete KD in dark green and those not meeting criteria but having prominent rash categorized as mixed rash in light green. Blue coloring indicated the respiratory phenotype.


Disclosures: S. Hong, None; E. Leisinger, None.

To cite this abstract in AMA style:

Hong S, Leisinger E. Characterizing Phenotypic Changes by SARS-CoV-2 Variant in Multisystem Inflammatory Syndrome in Children (MIS-C): A Single Institution Case Series [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/characterizing-phenotypic-changes-by-sars-cov-2-variant-in-multisystem-inflammatory-syndrome-in-children-mis-c-a-single-institution-case-series/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterizing-phenotypic-changes-by-sars-cov-2-variant-in-multisystem-inflammatory-syndrome-in-children-mis-c-a-single-institution-case-series/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology